Negative symptomatology: psychopharmacological strategies and methodological aspects for drug evaluation (Unknown)
- New search for: Benkert, O.
- New search for: Gerbaldo, H.
- New search for: Wetzel, H.
- New search for: Benkert, O.
- New search for: Gerbaldo, H.
- New search for: Wetzel, H.
In:
EUROPEAN NEUROPSYCHOPHARMACOLOGY
;
3
, 3
;
204
;
1993
-
ISSN:
- Article (Journal) / Print
-
Title:Negative symptomatology: psychopharmacological strategies and methodological aspects for drug evaluation
-
Contributors:
-
Published in:EUROPEAN NEUROPSYCHOPHARMACOLOGY ; 3, 3 ; 204
-
Publisher:
- New search for: ELSEVIER SCIENCE BV
-
Publication date:1993-01-01
-
Size:204 pages
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:Unknown
- New search for: 616.8 / 615.1
- Further information on Dewey Decimal Classification
-
Classification:
-
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 3, Issue 3
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 161
-
Serotonin and impulse control: From clinic to cloneLinnoila, M. / Higley, D. / Nielsen, D. / Andreason, P. / Suomi, S. / Goldman, D. / Virkkunen, M. et al. | 1993
- 162
-
Plasticity in expression of neuropeptidesHökfelt, T. / Castel, M.-N. / Morino, P. / Bean, A. / Ceccatelli, S. / Dagerlind, Å. / Zhang, X. / Verge, V. / Villar, M. / Schalling, M. et al. | 1993
- 164
-
Presynaptic receptors modulating neurotransmitter release: pharmacological characterization and therapeutic potentialLanger, S.Z. et al. | 1993
- 165
-
The diagnosis of Alzheimer's diseaseGottfries, C.G. et al. | 1993
- 166
-
The biochemical aspects and CSF markers in Alzheimer's diseaseBlennow, Kaj / Wallin, Anders / Gottfries, Carl-Gerhard et al. | 1993
- 168
-
Brain imaging and Alzheimer's diseaseScheltens, Ph. et al. | 1993
- 170
-
The cholinergic hypothesis of Alzheimer's diseaseSiegfried, K. et al. | 1993
- 172
-
Gangliosides selectively diminished in early onset Alzheimer's disease (AD type I) suggest synapse loss as primary eventSvennerholm, L. et al. | 1993
- 174
-
Histamine receptor subtypes: molecular pharmacologySchwartz, J.-C. / Traiffort, E. / Arrang, J.-M. / Tardivel-Lacombe, J. / Leurs, R. / Ruat, M. et al. | 1993
- 176
-
Receptor research: a challenge for drug developmentCarlsson, Arvid et al. | 1993
- 178
-
Rationale, development and implementation of the US Decade of the BrainJudd, L.L. et al. | 1993
- 179
-
Towards the European Decade of Brain ResearchGispen, W.H. et al. | 1993
- 181
-
Pharmacology of ionotropic and metabotropic glutamate receptorsLodge, David / Bond, Ann et al. | 1993
- 182
-
Inhibition of high-affinity glutamate uptake by arachidonic acid and oxygen free radicals: physiopathological significanceVolterra, A. / Trotti, D. / Floridi, S. / Mazza, F. / Racagni, G. et al. | 1993
- 184
-
Anti-excitatory amino acid approach in the treatment of neurodegenerative disordersMeldrum, B.S. et al. | 1993
- 186
-
Diagnosis and epidemiology of social phobiaLépine, J.P. et al. | 1993
- 188
-
Comorbidity and social phobia: evidence from epidemiologic and genetic studiesMerikangas, K.R. / Angst, J. et al. | 1993
- 190
-
Pharmacological treatment of social phobia; recent developmentsDen Boer, J.A. / van Vliet, I.M. / Westenberg, H.G.M. et al. | 1993
- 192
-
Biology of social phobiaDavidson, Jonathan R.T. / Potts, Nicholas / Krishnan, Ranga / Boyko, Orest / Charles, Cecil / Smith, Rebecca / Ford, Stephen / Tupler, Larry A. / Wilson, William et al. | 1993
- 193
-
Pharmacological treatment of social phobia: Traditional MAOIs and moclobemideLiebowitz, M.R. et al. | 1993
- 195
-
Galanin: potential role in learning and memoryÖgren, S.O. / Andersson, P. / Pramanik, A. et al. | 1993
- 196
-
Action of cholecystokinin on behaviorFekete, M. / Szántó-Fekete, M. et al. | 1993
- 198
-
ACTH neuropeptides and recovery after brain damageWolterink, G. / Vos, P.E. / van Ree, J.M. et al. | 1993
- 200
-
Social memory and neurohypophyseal hormonesPopik, Piotr / Vetulani, Jerzy / van Ree, Jan M. et al. | 1993
- 202
-
Dementia in normal pressure hydrocephalus and cerebrospinal fluid peptidesGjerris, A. / Gjerris, F. / Widerlöv, E. / Ekman, R. et al. | 1993
- 204
-
Negative symptomatology: psychopharmacological strategies and methodological aspects for drug evaluationBenkert, O. / Gerbaldo, H. / Wetzel, H. et al. | 1993
- 205
-
Negative symptoms, DST and variability of response to neuroleptics in schizophreniaAltamura, A.C. / Percudani, M. / Mauri, M.C. et al. | 1993
- 207
-
Clinical assessment of the negative symptoms of schizophreniaBarnes, Thomas R.E. et al. | 1993
- 208
-
Outcome of positive and negative symptoms during neuroleptic therapy in schizophreniaVita, A. / Dieci, M. / Giobbio, G.M. / Comazzi, M. / Boato, P. / Invernizzi, G. et al. | 1993
- 210
-
Classical antipsychotics in the treatment of negative symptomsFleischhacker, W.W. / Whitworth, A.B. et al. | 1993
- 213
-
The role of antidepressants in the treatment of generalized anxiety disorder (GAD)Schweizer, Edward et al. | 1993
- 214
-
Pharmacological differences between brief and major depressionsMontgomery, D. / Evans, R. / Montgomery, S.A. et al. | 1993
- 215
-
Is severe depression a different illness? The pharmacological evidenceKasper, S. et al. | 1993
- 218
-
5-HT1A receptors and alcohol preferenceDe Vry, J. / Schreiber, R. / de Beun, R. / Opitz, K. et al. | 1993
- 220
-
Calcium entry blockers and drug addictionZvartau, E.E. / Kuzmin, A.V. / Patkina, N.A. et al. | 1993
- 221
-
Endogenous opioids in opiate addiction, influence of genotype and phenotypeBakalkin, G. / Nylander, I. / Terenius, L. et al. | 1993
- 223
-
Opiate antagonists and addictionvan Ree, Jan M. et al. | 1993
- 224
-
Gamma-hydroxybutyric acid (GHB) for treatment of ethanol dependenceLuigi Gessa, Gian / Diana, Marco / Fadda, Fabio / Colombo, Giancarlo et al. | 1993
- 226
-
Childhood onset obsessive compulsive disorderRapoport, J.L. / Leonard, H.L. / Swedo, S.E. et al. | 1993
- 227
-
The role of serotonin in compulsive behavior: an animal modelBridger, W.H. / Friedman, E. / Yadin, E. et al. | 1993
- 228
-
Molecular biology of serotonin receptors: relation to psychiatric disease statesCiaranello, R.D. et al. | 1993
- 229
-
Beyond the serotonin hypothesis of OCDGoodman, W.K. / Barr, L.C. / McDougle, C.J. / Price, L.H. et al. | 1993
- 230
-
An update on the genetics and neurobiology of Tourette's syndrome and its relationship to obsessive-compulsive disorderLeckman, J.F. / Pauls, D.L. / Goodman, W.K. / Peterson, B.S. / Chappell, P.B. / Cohen, D.J. et al. | 1993
- 231
-
Teasing out the puzzle of multiple ‘D-1-like’ vs. ‘D-2-like’ dopamine receptor subtypes: existence and functionWaddington, J.L. / Daly, S.A. / Downes, R.P. / Deveney, A.M. et al. | 1993
- 231
-
Teasing out the puzzle of multiple `D-I-like' vs. `D-2-like' dopamine receptor subtypes: existence and functionWaddington, J. L. / Daly, S. A. / Downes, R. P. / Deveney, A. M. et al. | 1993
- 232
-
Function and regulation of the D3 dopamine receptorSokoloff, P. / Martres, M.-P. / Levesque, D. / Diaz, J. / Pilon, C. / Lammers, C.H. / Dimitriadou, V. / Griffon, N. / Schwartz, J.-C. et al. | 1993
- 234
-
Therapeutic implications of dopamine D4 vs. D2 receptor selectivity and occupancyLahti, R.A. / Gill, G.S. / Tamminga, C.A. / Evans, D.L. / Stratman, N.C. / Figur, L.M. et al. | 1993
- 236
-
How do atypical antipsychotics work — clues from c-fos studiesFibiger, H.C. / Robertson, G.S. / Guo, N. et al. | 1993
- 238
-
Protein phosphorylation as intracellular target in the action of MAO-A inhibitors and other antidepressantsPerez, J. / Cagnoli, C. / Mori, S. / Tinelli, D. / Migliavacca, E. / Brunello, N. / Racagni, G. et al. | 1993
- 239
-
Pharmacological interactions with reversible MAOIs and clinical relevanceDingemanse, J. et al. | 1993
- 241
-
Efficacy of reversible MAOIs in severely depressed and suicidal patientsAngst, J. et al. | 1993
- 242
-
Reversible monoamine oxidase-A inhibitors in dysthymia and other psychiatric indicationsLapierre, Y.D. / Ravindran, A. / Bakish, D. et al. | 1993
- 243
-
MAOIs and performanceO'Hanlon, J.F. et al. | 1993
- 245
-
Pharmacological and biochemical properties of central 5-HT3 and 5-HT4 receptorsMestikawy, S.El. / Emerit, M.B. / Miquel, M.C. / Gozlan, H. / Hamon, M. et al. | 1993
- 246
-
The behavioural pharmacology of the 5-HT3 receptor antagonistsCostall, B. / Naylor, R.J. et al. | 1993
- 248
-
A functional role for 5-HT4 receptors in the brain?Naylor, R.J. / Costall, B. / Kelly, M.E. et al. | 1993
- 250
-
Efficacy of 5HT3 receptor antagonistsLecrubier, Y. et al. | 1993
- 253
-
CCK provocation as a research tool in panic disorderBourin, M. / Bradwejn, J. / Vasar, E. / Palmour, R. et al. | 1993
- 256
-
Serotonin function and panic disorderKahn, R.S. et al. | 1993
- 258
-
The role of serotonin and cholecystokinin in panic disorderWestenberg, Herman G.M. / Den Doer, Johan A. / van Megen, Harold J.G.M. et al. | 1993
- 259
-
Benzodiazepine receptors and panicNutt, D. / Coupland, N. / Potokar, J. / Lillywhite, A. / Wilson, S. / Bailey, J. et al. | 1993
- 261
-
Panic disorder: the long-term perspectiveKatschnig, H. / Amering, M. et al. | 1993
- 263
-
Cellular and subcellular location of GABAA receptor subtypes and their pharmacological significanceMohler, H. / Benke, D. / Knoflach, F. / Fritschy, J.M. et al. | 1993
- 264
-
Probing the central type benzodiazepine binding site by use of receptor subtype mutantsLüddens, Hartmut / Seeburg, Peter H. et al. | 1993
- 266
-
Preclinical and clinical pharmacology of the novel anxiolytic, abecarnilStephens, D.N. et al. | 1993
- 268
-
Isoniazid-induced inhibition of GABAergic transmission enhances the efficacy of imidazenil, a new partial agonist of benzodiazepine receptorsBiggio, G. / Serra, M. / Ghiani, C.A. / Giusti, P. et al. | 1993
- 270
-
Preclinical dependence liability of benzodiazepine receptor partial agonistsMartin, J.R. et al. | 1993
- 272
-
Treatment of impulse control disordersGibert-Rahola, J. et al. | 1993
- 273
-
Suicide and peptidesBanki, C.M. et al. | 1993
- 275
-
Impulsivity in everyday life: the role of platelet MAOLópez-Ibor, Juan J. Jr. / Carrasco, JoséL. / Saiz, Jerónimo et al. | 1993
- 277
-
Isozyme specific drug oxidation: Genetic polymorphism and drug-drug interactionsBrøsen, K. et al. | 1993
- 279
-
Risk factor in antidepressant therapyGram, L.F. et al. | 1993
- 279
-
Risk factors in antidepressant therapyGram, L. F. et al. | 1993
- 280
-
The safety of antidepressant drugs in cardiovascular diseaseGlassman, Alexander H. / Roose, Steven P. et al. | 1993
- 281
-
Cardiac and central nervous system toxicity of antidepressants in relation to drug levelsPreskorn, S.H. et al. | 1993
- 283
-
Long-term treatment with antidepressantsMontgomery, S.A. et al. | 1993
- 285
-
Changes in serotonergic indices during treatment of patients with obsessive-compulsive disorderMarazziti, D. / Rotondo, A. / Milanfranchi, A. / Ravagli, S. / Lenzi, P. / Palego, L. / Presta, S. / Cassano, G.B. et al. | 1993
- 286
-
Comparison of serotonergic versus non-serotonergic medication in obsessive-compulsive disorder and panic disorderKindler, S. / Sasson, Y. / Zohar, J. et al. | 1993
- 288
-
Compulsive personality and serotonergic drugsAnsseau, M. / Troisfontaines, B. / Papart, P. / von Frenckell, R. et al. | 1993
- 289
-
Is long-term treatment effective in OCD?Fineberg, N.A. / Montgomery, D. / Evans, R. / Montgomery, S.A. et al. | 1993
- 289
-
As long-term treatment effective in OCD?Fineberg, N. A. / Montgomery, D. / Evans, R. / Montgomery, S. A. et al. | 1993
- 291
-
Preferential response of serotonergic medications in OCD related disordersHollander, E. / DeCaria, C. / Stein, D. / Simeon, D. / Hwang, M. / Cohen, L. et al. | 1993
- 294
-
The structure and function of sodium-coupled neurotransmitter transportersKanner, B.I. et al. | 1993
- 295
-
Molecular characterization of the serotonin transporterGraham, D. / Langer, S.Z. et al. | 1993
- 297
-
Molecular modelling of drug-transporter interactionsDahl, S.G. / Edvardsen, Ø. et al. | 1993
- 298
-
Clinical aspects of a specific GABA uptake inhibitorMengel, H.B. / Christensen, M.S. et al. | 1993
- 300
-
Modulation of transporter systems in brain: therapeutic implicationsAckenheil, M. / Bondy, B. / Würl, D. et al. | 1993
- 302
-
5-HT1 receptors in depression and related disordersLesch, K.P. et al. | 1993
- 303
-
Modulation of 5-HT neurotransmission by 5-HT1D receptors: possible therapeutic relevanceBlier, P. et al. | 1993
- 305
-
5HT receptor subtypes in anxiety disorders and depressionLeonard, B.E. et al. | 1993
- 306
-
Neuroendocrine probes for 5-HT receptor subtypesCowen, P.J. et al. | 1993
- 308
-
Affective, behavioral, and other non-endocrine physiologic responses to agonists and antagonists in humansMurphy, D.L. / Pigott, T.A. / Grady, T.A. / Lawlor, B. / Broocks, A. / Jacobsen, F. / Rosenthal, N. / Aulakh, C. / Lesch, K.-P. / Sunderland, T. et al. | 1993
- 310
-
Target receptors for hypnotics: Relevance to pharmacological profile and therapeutic actionZivkovic, B. / Arbilla, S. / Sanger, D.J. / Depoortere, H. / Scatton, B. / Langer, S.Z. et al. | 1993
- 311
-
Current treatment in the management of chronic insomiaMonti, J.M. et al. | 1993
- 311
-
Current treatment in the management of chronic insomniaMonti, J. M. et al. | 1993
- 313
-
An overview of classical and novel drugs in the treatment of insomniaLader, M. et al. | 1993
- 314
-
Future strategies in the treatment of sleep disordersGarreau, M. / De La Giclais, B. et al. | 1993
- 316
-
Sleep architecture effects as predictors of response to treatmentLinkowski, P. / Kerkhofs, M. / Kempenaers, C. / Staner, L. / Mendlewicz, J. et al. | 1993
- 317
-
Pupillary measures as markers of drug responseSzabadi, E. / Bradshaw, C.M. et al. | 1993
- 317
-
Papillary measures as markers of drug responseSzabadi, E. / Bradshaw, C. M. et al. | 1993
- 319
-
Use of a single-dose test of antidepressants as a pharmacological probePringuey, D. / Capdeville, C. / Belugou, J.L. / Talichet, L. / Feuillade, Ph. / Darcourt, G. et al. | 1993
- 321
-
Hormonal markers of response to antidepressive treatmentMöller, H.-J. / Kasper, S. et al. | 1993
- 323
-
A double-blind comparison of paroxetine and fluvoxamine in major depressionAnsseau, M. / Gabriëls, A. / Loyens, J. / Bartholomé, F. / Evrard, J. / De Nayer, A. / Linhart, R. / Wirtz, J. / Bruynoghe, F. / Surinx, K. et al. | 1993
- 323
-
Seizure duration and therapeutic efficacy of ECT in therapy refractory depressionHoeflich, G. / Kasper, S. / Ruhrmann, S. / Scholl, H.-P. et al. | 1993
- 323
-
Seizure duration and therapeutic efficacy of of ECT in therapy refractory depressionHöflich, G. / Kasper, S. / Ruhrmann, S. / Scholl, H.-P. / Danos, P. / Hawellek, B. / Möller, H.-J. et al. | 1993
- 324
-
Depression and associated anxiety in primary care: A double-blind comparison of paroxetine and amitriptylineStott, P.C. / Blagden, M.D. / Aitken, C.A. et al. | 1993
- 325
-
Dose and profile of citalopram in the management of depressive illnessRasmussen, J.C.G. / Montgomery, S.A. / Jacobsen, L.V. / Tanghøj, P. et al. | 1993
- 326
-
Fluoxetine in depressive episodes during prophylactic lithium treatmentTondo, L. / Masia, M. / Silvetti, F. / Spada, S. / Tarquini, A. / Loddo, S. / Rudas, N. et al. | 1993
- 327
-
Mociobemide: an open clinical trialMilanova, V. / Ivanov, B. / Kissiova, K. / Atchkova, M. et al. | 1993
- 327
-
Moclobemide - an open clinical trialMilanova, V. / Ivanov, B. / Kissiova, K. / Atchkova, M. et al. | 1993
- 327
-
A meta-analysis of published fluvoxamine studies in hospitalized depressed patients: a comparison with tri- and tetracyclic antidepressantsOttevanger, E.A. et al. | 1993
- 328
-
Moclobemide in treatment-resistant depressionDa̧bkowska, M. / Rybakowski, J.K. et al. | 1993
- 329
-
Moclobemide versus fluoxetine for a major depressive episodeReynaert, C. / Parent, M. / Mirel, J. / Janne, P. / Haazen, L. et al. | 1993
- 330
-
Dothiepin vs. S-adenosylmethionine (SAMe) for the treatment of major depression in weaned alcoholics: a pilot studySchifano, F. / Garofoli, F. et al. | 1993
- 331
-
The efficacy and tolerability of dothiepin versus serotonin specific reuptake inhibitors in the treatment of depressionDonovan, S. et al. | 1993
- 332
-
Specificity of dothiepin efficacy in depressed patients with somatic symptomsSchmitt, L. / de Sahb, R. / Boudet, A. / Goehrs, J.M. et al. | 1993
- 333
-
Long-term treatment of depression by tianeptineSarteschi, P. / Bersani, G. / Ciani, N. / Corsini, G.U. / Del Zompo, M. / De Maio, D. / Guazzelli, M. / Levi-Minzi, A. / Marano, P. / Nicoletti, F. et al. | 1993
- 333
-
Efficacy and acceptability of tianeptine in major depressive disorder and in dysthymia (DSM-IIIR) with somatic complaints: double blind study versus fluoxetineAlby, J.M. / Cabane, J. / Ferreri, M. / Bougerol, T. et al. | 1993
- 334
-
10 years evaluation of the diagnostic and therapeutic value of the lithium transport ratio in bipolar disorder: preliminary reportGalli, E. / Mazzotti, G. / Poletti, G. / Gallo, C. / Poletti, L. / Cazorla, A. et al. | 1993
- 335
-
Interindividual variation in serum zuclopenthixol concentrations: implications for the treatment of acute maniaLicht, R.W. / Thomsen, K. / Olesen, O.V. / Poulsen, J.H. et al. | 1993
- 336
-
Fluoxetine treatment and thyroid hormones in seasonal affective disorder (SAD)Ruhrmann, S. / Kasper, S. / Hawellek, B. / Biersack, H.-J. / Möller, H.-J. et al. | 1993
- 336
-
Suicidal behavior in bipolar disorder during lithium treatmentSpada, S. / Silvetti, F. / Tondo, L. / Masia, M. / Tarquini, A. / Meloni, E. / Rudas, N. et al. | 1993
- 337
-
Risk of 5-HT syndrome after co-administration of moclobemide (RIMA) and selective 5-HT re-uptake inhibitors (SSRI) — analysis of casesDelini-Stula, A. / Mikkelsen, H. et al. | 1993
- 338
-
Polysomnographic findings in psychotic depressives: a comparison with non-psychotic depressives matched for age, gender and polarityStefos, G. / Staner, L. / Hubain, Ph.P. / Van Veeren, C. / Kerkhofs, M. / Mendlewicz, J. / Linkowski, P. et al. | 1993
- 338
-
The dexamethasone suppression test in major depression: clinical and polysomnographic findingsHubain, Ph.P. / Staner, L. / Dramaix, M. / Kerkhofs, M. / Van Veeren, C. / Mendlewicz, J. / Linkowski, P. et al. | 1993
- 339
-
Changes in clinical symptoms, sleep EEG and nocturnal hormone secretion during treatment with trimipramine or imipramine — a double-blind comparison in patients with major depressionSteiger, A. / Sonntag, A. / Guldner, J. / Rothe, B. / Holsboer, F. et al. | 1993
- 340
-
Platelet 3H-paroxetine binding in depressed patients before and after treatment with fluoxetine and lofepramine, and in healthy volunteersKatona, C.L.E. / Robertson, M.M. / Abou-Saleh, M.T. / Lawrence, K.M. / Nairac, B.L. / Edwards, D.R.L. / Lock, T. / Burns, R. / Harrison, D.A. / Horton, R.W. et al. | 1993
- 341
-
Effect of fluvoxamine treatment on the plasma prolactin level in depressed patientsLandowski, J. / Sowiński, P. / Wichowicz, H. et al. | 1993
- 342
-
The TSH response to TRH in major depression: a multivariate approachHubain, Ph.P. / Staner, L. / Dramaix, M. / Kerkhofs, M. / Van Veeren, C. / Mendlewicz, J. / Linkowski, P. et al. | 1993
- 342
-
Altered microheterogeneity of α1-acid glycoprotein in endogenous depressionSłuzewska, A. / Rybakowski, J.K. / Sobieska, M. / Wiktorowicz, K. et al. | 1993
- 343
-
Antidepressants: Is there a correlation between their analgesic and antidepressant effect?Casas, J. / Gilbert, J. / Valverde, O. / Tejedor, P. / Romero, P. / Micó, J.A. et al. | 1993
- 344
-
The interaction of antidepressant drugs with neurotransmitter receptor binding sites and 5-HT uptake sites in human brain in vitroHorton, R. W. / De Paermentier, F. / Lowther, S. / Lawrence, K. M. et al. | 1993
- 344
-
The interaction of antidepressant drugs with neurotransmitter receptor bidning sites and 5-HT uptake sites in human brain in vitroHorton, R.W. / De Paermentier, F. / Lowther, S. / Lawrence, K.M. / Crompton, M.R. / Tulloch, I.F. et al. | 1993
- 345
-
The effect of antidepressant drugs and nifedipine in the forced swimming tests in ratsCzyrak, A. et al. | 1993
- 345
-
The effect of antidepressant drugs and nifedipine in the forced swimming test in ratsCzyrak, A. et al. | 1993
- 346
-
Reduction of learned helplessness by (-)deprenylGyarmati, Zs. / Timár, J. / Knoll, B. / Knoll, J. et al. | 1993
- 347
-
Antidepressant effects of S.14506 in the learned helplessness test in ratsLacroix, P. / Rocher, N. / Martin, P. / Mocaer, E. et al. | 1993
- 347
-
Antidepressant effects of medifoxamine in the learned helplessness test in ratsLacroix, P. / Rocher, N. / Martin, P. / Lemonnier, F. et al. | 1993
- 348
-
Similar effect of chronic treatment with imipramine and the NMDA antagonists CGP 37849 and MK-801 in a chronic mild stress model of depression in ratsPapp, M. / Moryl, E. et al. | 1993
- 349
-
Effect of antidepressant drugs or electroconvulsive shock and nifedipine on the rat hippocampal corticosteroid receptorsPrzegaliński, E. / Budziszewska, B. et al. | 1993
- 350
-
Carbamazepine in borderline personality disorderDe la Fuente, J.M. / Lotstra, F. et al. | 1993
- 351
-
Partial characterization of 3H-imipramine and 3H-paroxetine binding sites from calf striatum cerebral membranesRotondo, A. / Giannaccini, G. / Quattrone, K. / Marazziti, D. / Martini, C. / Lucacchini, A. / Cassano, G.B. et al. | 1993
- 352
-
Neurochemical effects of tianeptine on stress mechanismsGobbi, M. / Consolo, S. / Sacchetti, G. / Mennini, T. et al. | 1993
- 353
-
Effects of dothiepin and fluoxetine on sleep and morning psychomotor function in depressed patientsMoon, C.A.L. / Jago, W. / Pownall, R. / Welch, C.P. et al. | 1993
- 354
-
Do new antidepressants influence body weight? Comparing moclobemide to fluoxetineReynaert, C. / Parent, M. / Mirel, J. / Janne, P. / Haazen, L. et al. | 1993
- 355
-
Efficacy of moclobemide on mild and moderate depression; a comparison of dysthymic disorder and major depressionÖztürk, E. / Türkcapar, H. / Sirin, A. / Göka, E. / Özbay, H. et al. | 1993
- 355
-
A combined treatment of bright light therapy and hypericine versus hypericine monotherapy in seasonal affective disordersMartinez, B. / Kasper, S. / Ruhrmann, S. / Möller, H.-J. et al. | 1993
- 356
-
Validation of the Newcastle Scale through sleep polysomnographic studies in major depression: comparison with age matched controlsSouery, D. / Hubain, Ph.P. / Joenck, L. / Van Veeren, C. / Kerkhofs, M. / Staner, L. / Mendlewicz, J. / Linkowski, P. et al. | 1993
- 357
-
Psychosocial predictors of recurrences in recovered unipolar and bipolar patients on medication prophylaxis: a controlled prospective studyStaner, L. / Dramaix, M. / Bauwens, F. / Pardoen, D. / Mendlewicz, J. et al. | 1993
- 357
-
Classification of depressive illness following neuroendocrine and sleep abnormalities: a multivariate studyStaner, L. / Linkowski, P. / Mendlewicz, J. et al. | 1993
- 358
-
Methysergide and ritanserin effects on the TRH test in depressionPapakostas, Y. / Papadimitriou, G. / Markianos, M. / Zervas, I. / Papakostas, G. / Stefanis, C. et al. | 1993
- 359
-
Randomized, double-blind, parallel, multi-centre study of moclobemide vs. clomipramine in depressive patients in general practiceKragh-Sørensen, P. / Müller, B.M. / Andersen, Jens Vang / Buch, D. et al. | 1993
- 360
-
Biological markers of depression: relationship to endogenicity and severity of depressionVan Veeren, C. / Staner, L. / Kerkhofs, M. / Hubain, Ph.P. / Linkowski, P. et al. | 1993
- 360
-
Does intravenous clomipramine speed up the recovery process for depression?Wuilmart, Ph. / Mirel, J. et al. | 1993
- 361
-
Pharmacotherapy of depressive disorders in mentally retarded personsMunjiza, M.G. et al. | 1993
- 361
-
Paroxetine and driving performance — a comparative study with doxepine in healthy volunteersLudwig, M. / Herberg, K.-W. et al. | 1993
- 362
-
Fluvoxamine superior to imipramine in suicidal depressed patientsOttevanger, E.A. et al. | 1993
- 362
-
Flavoxamine superior to imipramine in suicidal depressed patientsOttevanger, E. A. et al. | 1993
- 363
-
Behavioural responses to olfactory bulbectomy in rats maintained in reversed cycle lightingKelly, J.P. / Norman, T.R. / Leonard, B.E. et al. | 1993
- 364
-
Are benzodiazepines useful in the treatment of generalized anxiety disorders?Lavallée, Y.J. / Jolicoeur, F.B. / Lepage, D. / Boulenger, J.P. et al. | 1993
- 365
-
Lack of interaction between buspirone and triazolamBoulenger, J.P. / Gram, L. / Jolicoeur, F.B. / Zarifian, E. et al. | 1993
- 366
-
Imipramine in panic disorder: dose-response and plasma level-response relationshipsMavissakalian, M.R. / Perel, J.M. et al. | 1993
- 367
-
Pharmacokinetics and pharmacodynamics of midazolam following oral and sublingual administration to healthy volunteersCrevoisier, Ch. / Gieschke, R. / Heizmann, P. / Ziegler, W.H. et al. | 1993
- 368
-
Effect of ritanserin on the neuroendocrine and temperature responses to flesinoxanAnsseau, M. / Jammaer, R. / Réel, C. / Wauthy, J. / Lembreghts, M. / Pitchot, W. / Moreno, A.Gonzalez / Sulon, J. / Legros, J.J. et al. | 1993
- 368
-
Effect of pindolol on the neuroendocrine and temperature responses to flesinoxanAnsseau, M. / Jammaer, R. / Réel, C. / Wauthy, J. / Lembreghts, M. / Pitchot, W. / Moreno, A.Gonzalez / Sulon, J. / Legros, J.J. et al. | 1993
- 369
-
Ultrasonic calls of male rats in anticipation of aversive stimulation: Pharmacological validation as an anxiety modelvan der Poel, A.M. / Molewijk, H.E. / Vedder, A.W. / Mos, J. / Olivier, B. et al. | 1993
- 371
-
Is the hippocampus important for the anti-emotional action of benzodiazepines and 5-HT1A receptor agonists?Plaznik, A. / Kostowski, W. et al. | 1993
- 370
-
Effects of two 5-HT1A agonist with anxiolytic properties: S 14506 and S 20499, on sleep-wakefulness regulations in the ratAdrien, J. / Desfemmes, T. / Maudhuit, C. / Hamon, M. et al. | 1993
- 370
-
Effects of two 5-HT~1~A agonists with anxiolytic properties: S 14506 and S 20499: on sleep-wakefulness regulations in the ratAdrien, J. / Desfemmes, T. / Maudhuit, C. / Hamon, M. et al. | 1993
- 371
-
Involvement of the dorsal hippocampus in mediation of the anticonflict effects of 5-HT1A agonistsTatarczyńska, E. / Filip, M. / Ko̵dzińska, A. et al. | 1993
- 372
-
Anxiolytic effect of paroxetine in the rat social interaction model of anxiety: Comparison with sertralineLightowler, S. / Williamson, I.J.R. / Kennett, G.A. / Tulloch, I.F. et al. | 1993
- 372
-
Anxiolytic effect of paroxetine in the rat social interaction model of anxiety: comparison with setralineLightowler, S. / Williamson, I. J. R. / Kennett, G. A. / Tulloch, I. F. et al. | 1993
- 373
-
At pharmacologically active doses chronic moclobemide lacks anxiolytic-like activity in the rat social interaction modelLightowler, S. / Kay, S.L. / Williamson, I.J.R. / Brazell, M.P. / Kennett, G.A. / Tulloch, I.F. et al. | 1993
- 374
-
Long-term treatment with citalopram in panic disorderLepola, U. / Leinonen, E. / Koponen, H. / Turtonen, J. et al. | 1993
- 374
-
Paroxetine in the treatment of panic disorderJudge, R. / Ohrstrom, J. / Manniche, P. / Christiansen, P. / Oehrberg, S. / Behnke, K. / Borup, A. / Severin, B. / Soegaard, J. / Calberg, H. et al. | 1993
- 375
-
Neuroendocrine and hypothermic effects of intravenous injection of the selective 5-HT1A receptor agonist flesinoxan in humansBenkelfat, C. / Blier, P. / Seletti, B. / Gilbert, F. / de Montigny, C. et al. | 1993
- 376
-
Effects of litoxetine on psychomotor performance and cognitive function in healthy volunteersPatat, A. / Hindmarch, I. / Curson, V.H. et al. | 1993
- 377
-
Exercise tolerance in panic disorder patientsPapp, L.A. / Gorman, J.M. et al. | 1993
- 377
-
Flavoxamine-ritanserin combination in the treatment of panic anxiety with avoidance behaviorPols, H. J. / Griez, E. J. / Verburg, C. et al. | 1993
- 377
-
Fluvoxamine-ritanserin combination in the treatment of panic anxiety with avoidance behaviorPols, H.J. / Griez, E.J. / Verburg, C. et al. | 1993
- 378
-
Efficacy of a combined therapy with imipramine and cognitive behavior therapy in the treatment of panic disorderStrauss, W.H. / Bruck, M. / Wurthmann, C. / Klieser, E. et al. | 1993
- 379
-
Platelet 3H-paroxetine binding and personality features related to panic disorderFaludi, G. / Tekes, K. et al. | 1993
- 380
-
The effects of haloperidol on visual search, eye movements and psychomotor performanceKing, D.J. / Lynch, G. / Mannion, M.F. / Byth, W. et al. | 1993
- 381
-
The effects of remoxipride and chlorpromazine on saccadic eye movements and psychomotor performance in healthy volunteersKing, D.J. / Best, P. / Lynch, G. / Tiplady, B. / Yisak, W. et al. | 1993
- 382
-
Efficacy and tolerability of intramuscular followed by oral remoxipride and haloperidol in psychosis: a double blind controlled multicenter trialKahn, J.-P. / Burnat, G. / Holm, A.-C. / Albaret, C. et al. | 1993
- 382
-
Remoxipride in the treatment of dopaminomimetic-therapy-induced psychosis in Parkinson's disease: Five case historiesEriksson, L. / Olsson, J.O. et al. | 1993
- 383
-
Zuclopenthixol co-injection in acute exacerbation of chronic psychosisKoponen, H.J. / Bredbacka, P.-E. / Mahlanen, A. / Hagert, U. / Tolvanen, E. / Riihikangas, R. / Vuorenmaa, J. / Pohto, E. / Hänninen, K. / Lepola, U. et al. | 1993
- 384
-
Eltoprazine improves autistic symptoms in self-injurious mentally handicapped patientsTyrer, S.P. / Moore, P.B. et al. | 1993
- 385
-
Extrapyramidal side effect monitoring through anticholinergic antiparkinson drug prescribing in neuroleptic-treated patientsDiana, G. / Alegiani, S.Spila / Raschetti, R. et al. | 1993
- 386
-
CSF amine metabolites in schizophrenia and the prediction of suicidal behaviourCooper, S.J. / Kelly, C.B. / King, D.J. et al. | 1993
- 386
-
Therapeutic effect of clonazepam in neuroleptic-induced akathisiaPetit, P. / Bottaï, T. / Pujalte, D. / Hue, B. / Alric, R. / Pouget, R. et al. | 1993
- 387
-
CT scan in medicated and in never-medicated schizophrenicsMoussaoui, D. / Ktiouet, J.E. / Kjiri, S. / Jiddane, M. / Boukhrissi, N. / Paes, M. / Battas, O. et al. | 1993
- 388
-
Dopamine receptor occupancy and dynamics in normals and schizophrenic patients assessed by a new SPECT-based methodTuninger, E. / Sjöholm, H. / Rosén, I. / Levander, S. / Freccero-Rosman, K. / Saugstad, L.F. et al. | 1993
- 389
-
Verification of the informatic therapeutic prognosis to a chosen neuroleptic agent response in patients with paranoid schizophreniaHorodnicki, Jan M. / Pobocha, Jerzy / Kobiernicka, Zeneta et al. | 1993
- 390
-
Effects of the atypical antipsychotic remoxipride and some of its phenolic metabolites on brain monoamine synthesis and on spontaneous locomotor activity in the ratAhlenius, Sven / Ericson, Evalena / Hillegaart, Viveka / Wijkström, Agneta et al. | 1993
- 391
-
Some behavioural studies on the key rat metabolites of the new atypical antipsychotic agent remoxiprideJackson, David M. / Bengtsson, Annelie / Mohell, Nina A. et al. | 1993
- 392
-
Adrenal medulla as a target for dopaminergic drugsKujacic, M. / Carlsson, A. et al. | 1993
- 393
-
Antagonism by SCH-23390 of clozapine-induced hypothermia in the ratSalmi, P. / Ahlenius, S. et al. | 1993
- 394
-
Effects of remoxipride on conditioned avoidance behavior in the ratSalmi, P. / Ahlenius, S. et al. | 1993
- 395
-
Changes in platelet phospholipid content in treated and untreated schizophrenicsŘípová, D. / Němcová, V. / Farská, I. / Papežová, H. / Höschl, C. et al. | 1993
- 396
-
Atypical neuroleptic profile of S 14506, a high affinity 5-HT1A agonist with D-2 and 5-HT1C antagonist activitiesProtais, P. / Chagraoui, A. / Arbaoui, J. / Mocaër, E. et al. | 1993
- 397
-
Effects of chronic treatments with S 14506, haloperidol and raclopride on apomorphine-induced behaviors in miceProtais, P. / Chagraoui, A. / Arbaoui, J. / Mocaër, E. et al. | 1993
- 398
-
Subjective effects of neurolepticsNaber, D. et al. | 1993
- 398
-
Delayed effects of neonatal excitotoxic hippocampal damage in the rat: a potential model of schizophreniaLipska, Barbara K. / Jaskiw, George E. / Weinberger, Daniel R. et al. | 1993
- 399
-
Influence of remoxipride on extracellular concentrations of glutamate, dopamine and dopamine metabolites in the striatum of freely moving ratsMagnusson, O. / Mohringe, B. / Serrano, G. / Henriksson, I. et al. | 1993
- 400
-
The characteristics of poor outcome, ‘Kraepelinian’ schizophreniaFrecska, E. / Losonczy, M.F. / Keefe, R.S.E. / Silverman, J.M. / Davidson, M. / Davis, K.L. et al. | 1993
- 401
-
Neuropsychological correlates of central monoamine function in chronic schizophreniaHarvey, P.D. / Kahn, R.S. / Davidson, M. et al. | 1993
- 401
-
Treatment of behavioural disturbances and psychotic symptoms in the elderly remoxiprideKarlsson, I. / Robertsson, B. / Eriksson, L. / Olsson, J.-O. et al. | 1993
- 401
-
Treatment of behavioural disturbances and psychotic symptoms in the elderly with remoxiprideKarlsson, I. / Robertsson, B. / Eriksson, L. / Olsson, J.-O. / Olofsson, H. / Jacobsson, N.O. / Årnell, G. et al. | 1993
- 402
-
The effects of remoxipride: comparison with typical and atypical antipsychotics on schedule induced polydipsiaRyan, Christine N. / Evenden, John L. / Jackson, David M. et al. | 1993
- 403
-
Electroconvulsive therapy for treatment of therapy resistant paranoid-hallucinatory psychosis and Parkinson's diseaseHöflich, G. / Kasper, S. / Burghof, K.-W. / Möller, H.-J. et al. | 1993
- 404
-
Negative symptoms in schizophrenia: prognostic importance and response to neuroleptic treatmentSheikman, M.B. et al. | 1993
- 404
-
Biotransformation of remoxipride in rats. Concentration of remoxipride and its major phenolic metabolites in plasma and brainLundström, J. / Nilsson, L.B. / Ögren, S.-O. et al. | 1993
- 405
-
Tardive dyskinesia in schizophrenia and its association with treatment, symptomatology and cognitive functionCooper, S.J. / Doherty, M.M. / Waddington, J.L. et al. | 1993
- 405
-
The Wisconsin card sort test as a predictor of pharmacological response in schizophrenic patientsStrauss, W.H. / Klieser, E. et al. | 1993
- 407
-
Effect of diazepam and tetrabamate on recently detoxified alcoholics' all-night EEG sleepAubin, H.J. / Goldenberg, F. / Benoit, O. / Gillet, C. / Roullet, M.C. / Barrucand, D. et al. | 1993
- 408
-
Treatment of alcoholism with fluvoxamine (preliminary findings)Habrat, B. et al. | 1993
- 408
-
Efficacy of different pharmacologic treatments on alcohol abuse in heroin addictsMarchesi, G.F. / Ciccioli, C. / Baldoni, A. / Santone, G. / De Rosa, M.G.L. / Ricci Messori, M. et al. | 1993
- 409
-
A1 allele of the D2 dopamine receptor gene is associated with alcoholismSyvälahti, E.K.G. / Heikkilä-Kallio, U. / Pohjalainen, T. / Salaspuro, M. / West, C. / Hietala, J. et al. | 1993
- 410
-
Involvement of the temporal lobe in opioid addictionDanos, P. / Kasper, S. / Klemm, E. / Broich, K. / Krappel, Ch. / Höflich, G. / Overbeck, B. / Grünwald, F. / Biersack, H.-J. / Möller, H.-J. et al. | 1993
- 411
-
Quality of life in a methadone maintenance programTorrens, M. / San, L. / Garrell, E. / Castillo, C. / Martinez, A. / Domingo, A. et al. | 1993
- 411
-
Repeated amphetamine down-regulates glucocorticosteroid receptors in the rat hippocampusBudziszewska, B. / Lason, W. et al. | 1993
- 411
-
Quality of life in methadone maintenance programTorrens, M. / San, L. / Garrell, E. / Castillo, C. et al. | 1993
- 412
-
(-)Deprenyl — lack of inducing place preference conditioning in ratsTimár, J. / Gyarmati, Zs. / Knoll, B. / Barna, L. / Knoll, J. et al. | 1993
- 413
-
Acute effects of CDP-choline on middle cerebral artery blood flow velocities in Alzheimer's disease: a transcranial Doppler studyCaamaño, J. / Franco, A. / Gómez, M.J. / Novo, B. / Alvarez, X.A. / Fernández-Novoa, L. / Cacabelos, R. et al. | 1993
- 413
-
CDP-choline-induced brain mapping changes in patients with Alzheimer's disease (AD)Franco-Maside, A. / Caamaño, J. / Gómez, M.J. / Alvarez, A. / Fernández-Novoa, L. / Novo, B. / Cacabelos, R. et al. | 1993
- 414
-
Age-related changes in serum interleukin-1β and tumor necrosis factor-α levels in healthy control subjectsAlvarez, X.A. / Franco, A. / Fernández-Novoa, L. / Cacabelos, R. et al. | 1993
- 415
-
Physiological and ‘successful’ cerebral agingMarchesi, G.F. / Nardi, B. / Mariani, L. / Pannelli, G. / Ianni, P. et al. | 1993
- 416
-
Tianeptine reverses the anxiogenic effects of alcohol withdrawal in ratsFile, S.E. / Andrews, N. / Al-Farhan, M. et al. | 1993
- 416
-
Prognostic factors of benzodiazepine withdrawal syndrome during the first 28 days of benzodiazepine discontinuationCesana, B.M. / Petracca, A. / Chiroli, S. / Borghi, C. / Cassano, G.B. et al. | 1993
- 417
-
Effects of α-lipoic acid on mitochondrial dehydrogenases in cortical regions of post-mortem brain in dementia of Alzheimer typeFrölich, L. / Weinmüller, M. / Barth, N. / Murach, W. / Götz, M. / Dirr, A. / Gsell, W. / Beckmann, H. / Riederer, P. et al. | 1993
- 418
-
Assessment of the dependence potential of the putative 5-HT1A agonist anxiolytic S-20499 in ratsGoudie, A.J. / Leathley, M.J. / Cowgill, J. et al. | 1993
- 419
-
Effects of S.12024-2 on memory impairment in aged ratsLacroix, P. / Reymann, J.M. / Rocher, N. / Allain, H. / Castagne, I. / Guez, D. et al. | 1993
- 419
-
Benzodiazepines in addition to antidepressants in the treatment of depression. How high is the risk to induce dependence?Naber, D. / Holzbach, R. et al. | 1993
- 420
-
A behavioral model of neurodegeneration in the marmosetDe Salvia, M.A. / Robert, A.C. / Wilkinson, L.S. / Collins, P. / Robbins, T.W. / Everitt, B.J. / Muir, J.L. / Cuomo, V. et al. | 1993
- 421
-
Carbamazepine in the treatment of affective-alcoholic patientsMagyar, I.Gy. / Haszmann, A. / Molnár, Gy. / Hajdú, L. / Nagy, J.E. et al. | 1993
- 423
-
Effect of ethanolamine, phosphoethanolamine and glutamine on GABA and amino acids in rats undergoing alcohol withdrawalDoroshenko, Ye.M. / Vinitskaya, A.G. / Kanunnikova, N.P. et al. | 1993
- 423
-
Comparison of the cardiovascular effects of nefazodone, imipramine and placebo in healthy elderly volunteersBreuel, H.-P. / De Leenheer, I. / Coninx, L. / Gammans, R. et al. | 1993
- 424
-
Attempted therapy of benzodiazepine withdrawal symptoms with carbamazepineMunjiza, M.G. et al. | 1993
- 425
-
S9977-2 reduces learning impairment and brain interleukin-1β overproduction in rats with neurotoxic lesions in the nucleus basalis of MeynertAlvarez, X.A. / Franco, A. / Rettori, M.-C. / Kamoun, A. / Polo, E. / Cacabelos, R. et al. | 1993
- 427
-
Effects of angiotensin II on brain hyperexcitabilityGeorgiev, V.P. et al. | 1993
- 427
-
Differential additive effects of carbamazepine with a calcium antagonist and a 5-HT1A agonistWalden, J. / von Wegerer, J. / Bingmann, D. / Fritze, J. et al. | 1993
- 428
-
Dose-response and time curve of inositol prevention of Li-pilocarpine seizuresBersudsky, Y. / Vinnitsky, I. / Grisaru, N. / Kofman, O. / Belmaker, R.H. et al. | 1993
- 429
-
Galanin antagonists M15 and M35: differential effects on striatal acetylcholine releaseÖgren, S.O. / Pramanik, A. / Land, T. / Langel, Ü. et al. | 1993
- 430
-
Changes in the rat choline uptake and CAT activity induced by the methylxanthine derivative S 9977-2 in ratsNieoullon, A. / Fourrier-Marguet, O. / Samuel, D. / Mocaër, E. / Rettori, M.C. / Kerkerian-Legoff, L. et al. | 1993
- 431
-
Measurement of horizontal reflex saccades, antisaccades and memory-guided saccades in humansLupp, A. / Duka, T. et al. | 1993
- 432
-
Plasma level monitoring of carbamazepine used in a major range of neuro-psychiatric diagnostic groupsMolnár, Gy. / Magyar, I.Gy. / Haszmann, A. / Dajka, K. et al. | 1993
- 433
-
KFM 19 antagonizes the adenosine-induced inhibition of electrically evoked acetylcholine releaseBechtel, W.D. et al. | 1993
- 434
-
Differential effects of high affinity sigma ligands on the NMDA response within rat hippocampus subfieldsMonnet, F.P. / Debonnel, G. / de Montigny, C. et al. | 1993
- 434
-
Brain hypometabolism in anorexia nervosa detected by the 18F-fluorodesoxyglucose method and positron emission tomographyDelvenne, V. / Lotstra, F. / Goldman, S. / Biver, F. / De Maertelaer, V. / Appelboom-Fondu, J. / Schoutens, A. / Bidaut, L. / Luxen, A. / Mendlewicz, J. et al. | 1993
- 434
-
C~6~0 proteins are involved in the potentiation of N-methyl-D-aspartate (NMDA) effects by sigma agonists and neuropeptideMonnet, Y. F. P. / Debonnel, G. / De Montigny, C. et al. | 1993
- 435
-
Transcriptional regulation of POMC gene by secretagoguesFágárásan, Mirela O. et al. | 1993
- 436
-
Effects of Arg8-vasopressin and des-Gly9-Arg8-vasopressin on locomotor activity in miceSpassov, V. / Getova, D. et al. | 1993
- 435
-
Gi/o proteins are involved in the potentiation of (NMDA) effects by sigma agonists and neuropeptide YMonnet, F.P. / Debonnel, G. / de Montigny, C. et al. | 1993
- 437
-
Effects of the glutamate antagonist glutamic acid diethyl ester on kainic acid seizuresGetova, D.P. / Georgiev, V.P. et al. | 1993
- 438
-
Long-term disruption of intracranial self-stimulation behaviour by lesion of the nucleus accumbens dopamine system: effect of ORG 2766 treatmentWolterink, G. / van Ree, J.M. et al. | 1993
- 439
-
The Ca2+-dependent release of serotonin induced by d-fenfluramine involves the P-type Ca2+ channels and protein kinase C activationFrittoli, E. / Cinquanta, M. / Gobbi, M. / Mennini, T. / Garattini, S. et al. | 1993
- 440
-
Effects of fluvoxamine and clomipramine treatment on beat-by-beat changes in blood pressure during standingWilson, S.J. / Lillywhite, A.R. / Coupland, N.J. / Potokar, J. / Bailey, J.E. / Nutt, D.J. et al. | 1993
- 441
-
Beat to beat monitoring of orthostatic hypotension — a comparison of phenelzine with moclobemideCoupland, N.J. / Wilson, S.J. / Bailey, J.E. / Potokar, J. / Nutt, D.J. et al. | 1993
- 442
-
Interactions between angiotensin II and certain GABAergic drugs in pentylenetetrazol kindling seizures in miceGeorgiev, V.P. / Lazarova-Bakarova, M.B. / Kamburova, T.S. et al. | 1993
- 443
-
Some central effects of CGP 37849 and related compounds — new competitive NMDA antagonistsMaj, J. / Rogóz, Z. / Skuza, G. / Klimek, V. et al. | 1993
- 444
-
Inducing differentiated emotion-feeling states in healthy volunteers: neurohormonal and neuroendocrine responsesBlin, O. / Philippot, P. / Dutour-Meyer, A. / Perpoli, P. / Valli, M. / Oliver, C. / Bruguerolle, B. / Rimé, B. et al. | 1993
- 445
-
Learning and retention in pentylenetetrazol-kindled ratsGenkova-Papazova, M.G. et al. | 1993
- 446
-
Opioid and adrenergic types of behaviour to stressCristea, A.N. et al. | 1993
- 446
-
Acute and subchronic effects of dothiepin, fluoxetine and placebo on psychometric performance and actual drivingRamaekers, J.G. / Muntjewerff, N.D. / O'Hanlon, J.F. et al. | 1993
- 447
-
Multiple neurochemical effect of sertraline treatment in the rat CNS: A quantitative autoradiographic study of catecholaminergic and benzodiazepine receptorsCalzà, L. / Zanni, M. / Velardo, A. / Giardino, L. et al. | 1993